NM_138711.6(PPARG):c.1116C>A (p.Phe372Leu) AND PPARG-related familial partial lipodystrophy

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 12, 2018
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000301823.5

Allele description [Variation Report for NM_138711.6(PPARG):c.1116C>A (p.Phe372Leu)]

NM_138711.6(PPARG):c.1116C>A (p.Phe372Leu)

Gene:

PPARG:peroxisome proliferator activated receptor gamma [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

3p25.2

Genomic location:

Preferred name:

NM_138711.6(PPARG):c.1116C>A (p.Phe372Leu)

HGVS:

NC_000003.12:g.12417090C>A
NG_011749.1:g.134241C>A
NM_001330615.4:c.729+11009C>A
NM_001354666.3:c.1116C>A
NM_001354667.3:c.1116C>A
NM_001354669.2:c.489C>A
NM_001374261.3:c.729+11009C>A
NM_001374262.3:c.729+11009C>A
NM_001374263.2:c.1116C>A
NM_001374264.2:c.1116C>A
NM_001374265.1:c.819+11009C>A
NM_001374266.1:c.653+11091C>A
NM_005037.7:c.1116C>A
NM_015869.5:c.1206C>A
NM_138711.6:c.1116C>AMANE SELECT
NM_138712.5:c.1116C>A
NP_001341595.2:p.Phe372Leu
NP_001341596.2:p.Phe372Leu
NP_001341598.1:p.Phe163Leu
NP_001361192.2:p.Phe372Leu
NP_001361193.2:p.Phe372Leu
NP_005028.5:p.Phe372Leu
NP_056953.2:p.Phe402Leu
NP_056953.2:p.Phe402Leu
NP_619725.3:p.Phe372Leu
NP_619726.3:p.Phe372Leu
NC_000003.11:g.12458589C>A
NM_015869.4:c.1206C>A

Protein change:

F163L

Links:

dbSNP: rs886057902

NCBI 1000 Genomes Browser:

rs886057902

Molecular consequence:

NM_001330615.4:c.729+11009C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001374261.3:c.729+11009C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001374262.3:c.729+11009C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001374265.1:c.819+11009C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001374266.1:c.653+11091C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001354666.3:c.1116C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001354667.3:c.1116C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001354669.2:c.489C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001374263.2:c.1116C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001374264.2:c.1116C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_005037.7:c.1116C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_015869.5:c.1206C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_138711.6:c.1116C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_138712.5:c.1116C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: PPARG-related familial partial lipodystrophy
Synonyms:: LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS; Familial partial lipodystrophy 3
Identifiers:: MONDO: MONDO:0011448; MedGen: C1720861; Orphanet: 79083; OMIM: 604367

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000440519	Illumina Laboratory Services, Illumina	criteria provided, single submitter (ICSL Variant Classification Criteria 13 December 2019)	Uncertain significance (Jan 12, 2018)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000440519

Illumina Laboratory Services, Illumina

criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)

Uncertain significance
(Jan 12, 2018)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000440519.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Jun 9, 2024

ClinVar

Relating variation to medicine